Marlborough, MA, United States of America

Gavin Charles Hirst

This inventor holds 4 USPTO granted patents. Top assignees: Glaxo Wellcome Inc., Glaxo Inc.. Active years: 1995-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gavin Charles Hirst. Retrieved from https://idiyas.com/inventor/gavin-charles-hirst

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Carrboro, NC (US) (1995 - 1996)
  • Marlboro, MA (US) (1999 - 2000)

Company Filing History:


Years Active: 1995-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Gavin Charles Hirst: Innovator in Pharmaceutical Chemistry

Introduction

Gavin Charles Hirst is a notable inventor based in Marlboro, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on the development of innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are the Oxoazepine derivatives and CCK or gastrin modulating benzodiazepine derivatives. These inventions showcase his expertise in creating novel chemical structures that can influence biological processes.

Career Highlights

Throughout his career, Gavin has worked with prominent companies in the pharmaceutical industry, including Glaxo Wellcome Inc. and Glaxo Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research.

Collaborations

Gavin has collaborated with talented individuals such as Milana Dezube and Elizabeth Ellen Sugg. These partnerships have fostered a creative environment that has led to the successful development of his patented inventions.

Conclusion

Gavin Charles Hirst is a distinguished inventor whose work in pharmaceutical chemistry continues to impact the industry. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…